Re: Critical Outcome Advances to Fourth Cohort in Phase 1 Study of COTI-2 in Gynecologic Cancers

Welcome To The Critical Outcome Technologies Inc HUB On AGORACOM

Our disease Targets > Small cell lung cancer, Multiple sclerosis, HIV Integrase, Colorectal cancer & Adult acute leukemia

Reply New Message

Prev Message Back To Forum Threaded View Next Message

langosta

Rank: President [?]

Points: 3835 [?]

Votes: 63 Score: 3.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Critical Outcome Advances to Fourth Cohort in Phase 1 Study of COTI-2 in Gynecologic Cancers

in response to

Re: Critical Outcome Advances to Fourth Cohort in Phase 1 Study of COTI-2 in Gynecologic Cancers

hoov

posted on Aug 27, 2018 03:35PM

This company seems to be dying on the vine. Great Partnerships, impressive Scientific Advisory Board, Small but what seems to be capable management, although what the recent changes infer is anyones guess.

Re: Orphan Drug Status, Under Orphan Drug Designations and Approvals, FDA.

could find nothing for COTI-2.

Good story but lack of cash could be the bogeyman. This board is also pretty well dead. Anyone got thoughts?

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply